Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

30.63
Delayed Data
As of Apr 21
 -0.19 / -0.62%
Today’s Change
20.79
Today|||52-Week Range
37.32
-8.57%
Year-to-Date

Today’s Trading

Previous close30.82
Today’s open30.79
Day’s range30.50 - 30.93
Volume103,941
Average volume (3 months)214,020
Market cap$583.2M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-72.37%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-45.13%
P/E ratioNM
Price/Sales5.80
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
PRTKParatek Pharmaceutic...+0.40+1.85%
ARDXArdelyx Inc-0.10-0.79%
SPPISpectrum Pharmaceuti...+0.12+1.72%
CTMXCytomX Therapeutics ...+0.34+2.11%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$88.3M
Annual profit (last year)$21.7M
Net profit margin24.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Jay R. Luly
CFO, Senior VP-Finance &
Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts


Search for Jobs